ANTX
MODERATEAN2 Therapeutics, Inc.
CIK: 0001880438
Last activity: 4 weeks ago
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (5 total, 5 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
Eizen Joshua M
See Remarks
|
0 | 2 | -$25K |
152,499 shares
$154K
|
|
Chanda Sanjay
Chief Development Officer
|
0 | 2 | -$9K |
75,823 shares
$77K
|
|
Day Lucy
Chief Financial Officer
|
0 | 2 | -$9K |
75,363 shares
$76K
|
|
Prior Stephen David
Chief Strategy Officer
|
0 | 2 | -$7K |
59,086 shares
$60K
|
|
Williams Sarah Joanne
Principal Accounting Officer
|
0 | 1 | -$347 |
66,848 shares
$71K
|
Recent Transactions
327 shares @ $1.06
$347
Mar 3, 2026
6,931 shares @ $1.01
$7K
Jan 6, 2026
5,956 shares @ $1.01
$6K
Jan 6, 2026
5,512 shares @ $1.01
$6K
Jan 6, 2026
2,858 shares @ $1.01
$3K
Jan 6, 2026
17,923 shares @ $1.00
$18K
Jan 5, 2026
3,604 shares @ $1.00
$4K
Jan 5, 2026
3,295 shares @ $1.00
$3K
Jan 5, 2026
3,295 shares @ $1.00
$3K
Jan 5, 2026
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.